Citation Impact
Citing Papers
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Circulating xanthine oxidase and neutrophil activation during human liver transplantation
1998
Methods for evaluation of platelet function
2009 StandoutNobel
Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice
2000 StandoutNobel
Liver and kidney preservation by perfusion
2002
The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilatin system
1998
Selecting the Donor Liver: Risk Factors for Poor Function After Orthotopic Liver Transplantation
1994
Immunosuppressive Drugs in Paediatric Liver Transplantation
2001
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Therapeutic drug monitoring of cyclosporine and tacrolimus
1998
Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation
1997
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
2002
Regional Hemostatic Status and Blood Requirements After Total Knee Arthroplasty With and Without Tranexamic Acid or Aprotinin
2001
Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation
1994
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
Comparative Effects of Small and Large Aprotinin Doses on Bleeding During Orthotopic Liver Transplantation
1995
Aprotinin Decreases Blood Loss and Homologous Transfusions in Patients Undergoing Major Orthopedic Surgery
1998
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
Tranexamic Acid
1999 Standout
Protection against post-ischemic mitochondrial injury in rat liver by silymarin or TUDC
2003
Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes
1998
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver Transplantation
1996
Die Wirkung von Aprotinin
1997
Nitric oxide synthases: structure, function and inhibition
2001 Standout
Effect of S-adenosylmethionine on hepatic injury from sequential cold and warm ischemia
2000
Biological modulation of renal ischemia–reperfusion injury
2010
Mitochondrial control of cell death
2000 Standout
Current strategies for the use of sub-optimal grafts in living donor liver transplantation
2002 StandoutNobel
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double-blind study
2001
Apheresis Therapy for Living‐Donor Liver Transplantation
2002 StandoutNobel
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
2009
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Liver Transplantation
1989
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Thrombelastography/thromboelastometry
2005
Atrial Natriuretic Peptide for Management of Acute Kidney Injury
2008
Enhanced Adenine Nucleotide Degradation in Chronic Obstructive Pulmonary Disease: The Effect of Oxygen Therapy
1989
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Predictive Factors of Early Postoperative Graft Function in Human Liver Transplantation
1994
Regional Hemostatic Status and Blood Requirements After Total Knee Arthroplasty With and Without Tranexamic Acid or Aprotinin
2001
Heme Oxygenase-1 Is a cGMP-Inducible Endothelial Protein and Mediates the Cytoprotective Action of Nitric Oxide
2000
Mitochondrial permeability transition during hypothermic to normothermic reperfusion in rat liver demonstrated by the protective effect of cyclosporin A
1998
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
1994 Standout
EARLY ALLOGRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION
1998
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Role of superoxide dismutases (SODs) in controlling oxidative stress in plants
2002 Standout
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
IMPACT OF GRAFT SIZE MISMATCHING ON GRAFT PROGNOSIS IN LIVER TRANSPLANTATION FROM LIVING DONORS1,2
1999
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation
2006
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
1994
Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation
1997
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of B. Ringe being referenced
Coagulation disorder during liver transplantation
1991
Pitfalls in Monitoring Tacrolimus (FK 506)
1997
Urodilatin: a new approach for the treatment of therapy‐resistant acute renal failure after liver transplantation
1994
The use of high dose aprotinin in liver transplantation: The influence on fibrinolysis and blood loss
1991
Tissue oxygen saturation of human hepatic grafts after reperfusion: paradoxical elevation in poor graft function
1996
ADENINE NUCLEOTIDE METABOLISM AND ITS RELATION TO ORGAN VIABILITY IN HUMAN LIVER TRANSPLANTATION1
1988
Extramedullary erythropoiesis in human liver grafts
1995
Growth in long-term survivors after orthotopic liver transplantation in childhood.
1994